Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Irbesartan is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. It was developed by Sanofi Research (now part of Sanofi-Aventis). It is jointly marketed by Sanofi-Aventis and Bristol-Myers Squibb under the trade names Aprovel, Karvea, and Avapro.
Medical uses
irbesartan intermediate
As with all angiotensin II receptor antagonists, irbesartan is indicated for the treatment of hypertension. Irbesartan may also delay progression of diabetic nephropathy and is also indicated for the reduction of renal disease progression in patients with type 2 diabetes, hypertension and microalbuminuria (>30 mg/24 hours) or proteinuria (>900 mg/24 hours).
irbesartan intermediate
Irbesartan is also available in a combination formulation with a low dose thiazide diuretic, invariably , to achieve an additive antihypertensive effect. Irbesartan/combination preparations are marketed under similar trade names to irbesartan preparations, including Irda, CoIrda, CoAprovel, Karvezide, Avalide and Avapro HCT.
A large randomized trial following 4100+ men and women with heart failure and normal ejection fraction (>=45%) over 4+ years found no improvement in study outcomes or survival with irbesartan as compared to placebo.
Medical uses
irbesartan intermediate
As with all angiotensin II receptor antagonists, irbesartan is indicated for the treatment of hypertension. Irbesartan may also delay progression of diabetic nephropathy and is also indicated for the reduction of renal disease progression in patients with type 2 diabetes, hypertension and microalbuminuria (>30 mg/24 hours) or proteinuria (>900 mg/24 hours).
Irbesartan is used to treat high blood pressure.
Irbesartan is used to protect kidney function in diabetic patients who have protein loss.
Irbesartan may be given to you for other reasons. Talk with the doctor.A